PER 0.00% 10.5¢ percheron therapeutics limited

Ann: Long COVID-19 strategic collaboration with US Experts, page-181

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 3,619 Posts.
    lightbulb Created with Sketch. 783
    Ok Sam...you might be 100% correct as it's possible that the first dosing might come in any time .

    Below from the announcement..

    Site evaluations completed. Site selection close to finalization for sites (>30) in 9 countries
    • Clinical trial agreements being executed with all trial sites and submission of the clinical trial application to be made to
    each of the national regulatory authorities
    • Trial approvals expected to come through on a rolling basis depending on ethics and reg approval requirements of the
    individual authorities

    It's strange how it's being put together...

    So it says Site selection close to finalzation..

    Next it says Clinical trial agreements executed with all trial site..so obviously does not add up...as agreements would only be executed if the sites are finalised and signed...and ANP needs these agreement as a part of submission / approval from individual authorities...so it's must be moving for sure ..

    And yes this should put a little rocket under the SP...along with some other pending announcements for June..
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
10.5¢
Change
0.000(0.00%)
Mkt cap ! $94.66M
Open High Low Value Volume
10.5¢ 10.5¢ 9.8¢ $58.09K 574.8K

Buyers (Bids)

No. Vol. Price($)
1 38503 10.0¢
 

Sellers (Offers)

Price($) Vol. No.
10.5¢ 194063 5
View Market Depth
Last trade - 16.10pm 04/10/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.